Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download case study

Ultra-rare disease case study

Sano is working with a biotech partner to find and engage patients with a specific genetic subtype of an ultra-rare disease across the US and Europe. The aim is to identify diagnosed, misdiagnosed, and undiagnosed individuals for future clinical research. Due to confidentiality, the condition and genetic target are not named.

We’ve combined insights from patient groups with targeted outreach, trusted advocacy partnerships, and a Virtual Waiting Room that keeps participants informed and supported. Concierge-style services help guide patients and sites through each step.

The program is already driving meaningful engagement and building a strong pipeline for upcoming studies—despite the challenges of low awareness, diagnostic barriers, and geographic dispersion.

Download the case study to see how Sano is helping reshape ultra-rare disease research.

ultrararecasestudy